Eli Lilly is getting its hands on a promising pipeline candidate thanks to an acquisition. The stock may not gain much more ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly and Company (NYSE:LLY) is one of the best long term growth stocks to buy according to hedge funds. On January 9, ...

Detailed price information for Ventyx Biosciences Inc (VTYX-Q) from The Globe and Mail including charting and trades.

With the planned purchase, Boston Scientific will gain a portfolio of devices to remove clots from blood vessels.

BioAge shares catapulted Monday on promising results for the company's cardiovascular diseases treatment, which could ...

Historically, JPM week has been marked by at least a handful of high-dollar, high-profile acquisition events. This year we ...

Eli Lilly (LLY) downgraded to Sell as obesity-drug competition and pricing pressure rise; stretched valuation boosts downside ...

Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has ...

Flushing Financial Corp. (NASDAQ: FFIC) related to its sale to OceanFirst Financial Corp. Under the terms of the proposed transaction, Flushing shareholders are expected to receive 0.85 of a share of ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...

"My pipeline in terms of number of IPOs at the SEC or working to get them into the SEC is bigger than I have ever had in my ...